[HTML][HTML] Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy

AD Wells, MC Walsh, JA Bluestone… - The Journal of clinical …, 2001 - Am Soc Clin Investig
AD Wells, MC Walsh, JA Bluestone, LA Turka
The Journal of clinical investigation, 2001Am Soc Clin Investig
Primary T cell proliferative responses to TCR ligation plus CD28 costimulation are
surprisingly heterogeneous. Many cells that enter G1 fail to progress further through the cell
cycle, and some of these cells subsequently fail to divide upon restimulation, even in the
presence of IL-2. Such IL-2–refractory anergy is distinct from the IL-2–reversible anergy
induced by TCR occupancy in the absence of CD28 costimulation. Here, we focus on the
contributions of cell cycle progression and costimulatory (CD28/CTLA-4) signals in the …
Primary T cell proliferative responses to TCR ligation plus CD28 costimulation are surprisingly heterogeneous. Many cells that enter G1 fail to progress further through the cell cycle, and some of these cells subsequently fail to divide upon restimulation, even in the presence of IL-2. Such IL-2–refractory anergy is distinct from the IL-2–reversible anergy induced by TCR occupancy in the absence of CD28 costimulation. Here, we focus on the contributions of cell cycle progression and costimulatory (CD28/CTLA-4) signals in the regulation of anergy. We show that CD28 costimulation is not sufficient for anergy avoidance and that activated T cells must progress through the cell cycle in order to escape anergy. Induction of this “division-arrest” form of anergy requires CTLA-4 signaling during the primary response. Also, cell division per se is not sufficient for anergy avoidance: the few T cells that undergo multiple rounds of cell division during overt CD28 costimulatory blockade do not escape the ultimate induction of clonal anergy. Anergy avoidance by primary T cells is thus a multistep process: in order to participate in a productive immune response, an individual T cell activated through its antigen receptor must receive CD28 costimulation and progress through the cell cycle. Anergy may be induced either through a combination of CTLA-4 signaling and the failure of cell cycle progression, or through a proliferation-independent mechanism in which TCR ligation occurs in the absence of CD28.
The Journal of Clinical Investigation